[
    [
        {
            "time": "",
            "original_text": "长春高新：拟与冰岛生物制药公司设合资公司",
            "features": {
                "keywords": [
                    "长春高新",
                    "冰岛",
                    "生物制药",
                    "合资公司"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "长春高新：拟与冰岛生物制药公司设合资公司",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "长春高新:生长激素超预期增长 多重因素促进疫苗高速增长",
            "features": {
                "keywords": [
                    "长春高新",
                    "生长激素",
                    "疫苗",
                    "高速增长"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "长春高新:生长激素超预期增长 多重因素促进疫苗高速增长",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "东吴医药行业周观点:带量采购政策不确定性导致行业大幅波动, 底部坚定推荐医药消费升级属性标的",
            "features": {
                "keywords": [
                    "东吴医药",
                    "带量采购",
                    "政策不确定性",
                    "行业波动",
                    "医药消费升级"
                ],
                "sentiment_score": -0.6,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "东吴医药行业周观点:带量采购政策不确定性导致行业大幅波动, 底部坚定推荐医药消费升级属性标的",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        }
    ]
]